Importance Multiple therapies are currently available for patients with neuroendocrine
tumors (NETs), yet many therapies have not been compared head-to-head within …

The majority of neuroendocrine tumors originate in the digestive system and incidence is
increasing within Canada and globally. Due to rapidly evolving evidence related to …

Neuroendocrine neoplasms (NENs) are derived from neuroendocrine cell system and can
have benign or malignant characteristics. They are rare tumors, but have been increasing in …

Neuroendocrine neoplasms (NENs) can develop in almost any organ and span a spectrum
from well-differentiated and indolent neuroendocrine tumours (NETs) to poorly differentiated …

Abstract Introduction Neuroendocrine tumors (NETs) represent a small proportion of
cancers, but are increasing in incidence due to incidental diagnosis. We examined NET …

Neuroendocrine tumors (NETs) originate from the neuroendocrine cell system in the
bronchial and gastrointestinal tract and can produce hormones leading to distinct clinical …

Neuroendocrine neoplasms are diverse in terms of sites of origin, functional status, and
degrees of aggressiveness. This review will introduce some of the common features of …

Neuroendocrine tumors (NETs) constitute a heterogeneous group of neoplasms with distinct
biological behaviors, depending on the site of origin and the degree of tumor proliferation …

We have come a long way in our understanding and treatment of neuroendocrine tumors
since the term “karzinoide” was coined in 1907. Neuroendocrine tumors are a group of …

Importance The incidence and prevalence of neuroendocrine tumors (NETs) are thought to
be rising, but updated epidemiologic data are lacking. Objective To explore the evolving …